12:00 AM
 | 
Sep 03, 2012
 |  BC Week In Review  |  Company News  |  Deals

GeneCentric Diagnostics, University of North Carolina deal

The university granted molecular diagnostic company GeneCentric exclusive, worldwide rights to commercialize Hypoxia Signature and exclusive rights to Lung Subtype Platform technology. Hypoxia Signature,...

Read the full 98 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >